166 related articles for article (PubMed ID: 8531072)
1. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.
Zeevalk GD; Derr-Yellin E; Nicklas WJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1124-30. PubMed ID: 8531072
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter.
Moy LY; Wang SP; Sonsalla PK
J Pharmacol Exp Ther; 2007 Feb; 320(2):747-56. PubMed ID: 17090704
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid.
Zeevalk GD; Derr-Yellin E; Nicklas WJ
J Neurochem; 1995 Jan; 64(1):455-8. PubMed ID: 7798946
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of malonate toxicity in primary mesencephalic cultures using the GABA transport blocker, NO-711.
Stokes AH; Bernard LP; Nicklas WJ; Zeevalk GD
J Neurosci Res; 2001 Apr; 64(1):43-52. PubMed ID: 11276050
[TBL] [Abstract][Full Text] [Related]
6. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
Fatokun AA; Smith RA; Stone TW
Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
[TBL] [Abstract][Full Text] [Related]
7. Role of oxidative stress and the glutathione system in loss of dopamine neurons due to impairment of energy metabolism.
Zeevalk GD; Bernard LP; Nicklas WJ
J Neurochem; 1998 Apr; 70(4):1421-30. PubMed ID: 9523558
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2A.
Zeevalk GD; Bernard LP; Manzino L; Sonsalla PK
J Pharmacol Exp Ther; 2001 Sep; 298(3):925-33. PubMed ID: 11504786
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.
Sanchez-Ramos J; Facca A; Basit A; Song S
Exp Neurol; 1998 Apr; 150(2):263-71. PubMed ID: 9527896
[TBL] [Abstract][Full Text] [Related]
10. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro.
Parga JA; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Dev Neurobiol; 2007 Oct; 67(12):1549-59. PubMed ID: 17525990
[TBL] [Abstract][Full Text] [Related]
11. 3-Nitropropionic acid neurotoxicity in organotypic striatal and corticostriatal slice cultures is dependent on glucose and glutamate.
Storgaard J; Kornblit BT; Zimmer J; Gramsbergen JB
Exp Neurol; 2000 Jul; 164(1):227-35. PubMed ID: 10877933
[TBL] [Abstract][Full Text] [Related]
12. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Villarán RF; Tomás-Camardiel M; de Pablos RM; Santiago M; Herrera AJ; Navarro A; Machado A; Cano J
Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658
[TBL] [Abstract][Full Text] [Related]
13. Preconditioning with NMDA protects against toxicity of 3-nitropropionic acid or glutamate in cultured cerebellar granule neurons.
Smith AJ; Stone TW; Smith RA
Neurosci Lett; 2008 Aug; 440(3):294-8. PubMed ID: 18565656
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate.
Greene JG; Greenamyre JT
J Neurochem; 1995 Jan; 64(1):430-6. PubMed ID: 7528265
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity.
Binienda ZK; Przybyla BD; Robinson BL; Salem N; Virmani A; Amato A; Ali SF
Ann N Y Acad Sci; 2006 Aug; 1074():74-83. PubMed ID: 17105904
[TBL] [Abstract][Full Text] [Related]
16. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism.
Zeevalk GD; Manzino L; Hoppe J; Sonsalla P
Eur J Pharmacol; 1997 Feb; 320(2-3):111-9. PubMed ID: 9059843
[TBL] [Abstract][Full Text] [Related]
17. L-2-chloropropionic acid-induced neurotoxicity is prevented by MK-801: possible role of NMDA receptors in the neuropathology.
Widdowson PS; Wyatt I; Gyte A; Simpson MG; Lock EA
Toxicol Appl Pharmacol; 1996 Jan; 136(1):138-45. PubMed ID: 8560467
[TBL] [Abstract][Full Text] [Related]
18. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
19. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
20. 3-Nitropropionic acid depresses spinal reflexes involving GABAergic and glycinergic transmission in neonatal rat spinal cord in vitro.
Gupta R; Deshpande SB
Life Sci; 2008 Nov; 83(21-22):756-60. PubMed ID: 18930740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
